Scarinci Hollenbeck, LLC
The Firm
201-896-4100 info@sh-law.comClient Alert
MLB Lawsuit May Inadvertently Target Players
Author: Scarinci Hollenbeck, LLC
Date: March 27, 2013
Key Contacts
Back
MLB Lawsuit Against BioGenesis
Major League Baseball’s recent lawsuit against Florida clinic BioGenesis may have unintended consequences for players, a new report shows.
MLB is currently suing the clinic for allegedly providing banned performance-enhancing drugs to the league’s players, a heavy sports law violation. Court documents show that MLB believes BioGenesis owner Anthony Bosch gave illicit performance enhancing drugs to nearly half a dozen players, according to Reuters. However, if the suit continues, the clinic may be forced to disclose medical records of players that visited the clinic, which could lead to disciplinary actions if it’s discovered that these players accepted these drugs, Reuters reports.
The league claims that by providing drugs to players, the action amounts to contract interference by “inducing” players to violate MLB’s drug prevention program. However, Reuters notes that these types of cases – which are typically used to go after business competitors – are difficult to win. Despite this analysis, the MLB said the case “has merit” and does not plan on shying away.
“We believe we have a legitimate legal claim against the defendants and we intend to pursue it vigorously,” said MLB spokesman Pat Courtney.
- Industries: Entertainment & Media
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Related Posts
See all
New Jersey’s NEW Mansion Tax
States have a problem. As costs and expenses rise, they must find new ways to raise revenue that is politically palatable that the taxpayers can live with. What is a state like New Jersey to do when it is staring at a $1.2 billion budget deficit? It already has exceedingly high property taxes. The sales […]
Author: Scott H. Novak
Beware of Scammers - Don’t Fall for These Trademark Scams
Many trademark scammers send official looking letters or emails urging immediate action to pressure you to pay them money for your trademark or “additional” services you do not require. If you ever receive a notice asking for payment as to your trademark from any such company, DO NOT PAY IT. To all our clients, we […]
Author: Ronald S. Bienstock
Nationwide Preliminary Injunction for CTA Filings Lifted
FinCEN Beneficial Owner Reporting Must be Completed by January 13 for pre-2024 Companies On December 23, 2024, the 5th Circuit Court of Appeals lifted the injunction that stayed the enforcement of the Corporate Transparency Act put into place by a federal judge in Texas. The result is that if you are required to file a […]
Author: Scott H. Novak
FinCEN Corporate Transparency Act filings shut down by the US District Court for the Eastern District of Texas
IMPORTANT UPDATE! FinCEN Corporate Transparency Act filings shut down by the US District Court for the Eastern District of Texas Under the Corporate Transparency Act (CTA), entities that were in existence before January 1, 2024 are required to file Beneficial Owner Reports (BOR) with the Financial Crimes Enforcement Network (FinCEN) before January 1, 2025. Requirements […]
Author: Scott H. Novak
New Intoxicating Hemp Law Will Dramatically Affect New Jersey Cannabis, Hemp, and Liquor Industries
On September 12, 2024, Gov. Phil Murphy signed controversial legislation that will dramatically alter New Jersey’s cannabis, hemp, and liquor industries. The new law aims to regulate the influx of intoxicating hemp products into the marketplace by bringing them under the purview of the New Jersey Cannabis Regulatory Commission (CRC). That means that edibles, THC-infused beverages, […]
Author: Daniel T. McKillop
Wheels Moving on Reclassification of Cannabis as AG Launches Rulemaking Process
On May 16, 2024, President Joe Biden announced that his administration is committed to reclassifying cannabis. Shortly thereafter, Attorney General Merritt Garland initiated the formal rulemaking process to move cannabis from a Schedule I to a Schedule III drug under the Controlled Substances Act (CSA). “This is monumental,” President Biden said in a video statement […]
Author: Daniel T. McKillop
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.